Studies in Mct8-deficient mice and AHDS patients have already revealed that both compounds are capable of lowering endogenous TH production and normalizing symptoms of a peripheral thyrotoxicosis (such as hypermetabolism, muscle wasting, and increased heart rate) [18,19,20,21]. Here, TH is linked to thyrotoxicosis.